Olympus Offers Middleware Solution for Clinical Laboratories
Center Valley, PA, May 28, 2008- Olympus America Inc. has an agreement with Data Innovations, Inc. to provide U.S. customers with middleware powered by the Data Innovations Instrument Manager™. The agreement between the companies provides laboratories with advanced features to manage data from Olympus AU® Chemistry and AU3000i® immunoassay systems and to optimize routing, tracking, and archiving of specimen tubes for the Olympus OLA2500™ automation systems. By using customized rules-based decision processing and auto-verification middleware solutions, laboratories can improve the quality and turnaround time for patient data and reduce personnel time for review and management of workflow.
The agreement gives Olympus the rights to distribute the Data Innovations Instrument Manager™ in the U.S. Olympus will provide all sales, marketing, service and support of the middleware system. Data Innovations will provide customer training at their facility and through their web-based services.
“Providing middleware continues the expansion of Olympus’ analytical and automation solutions, which improve the quality and timeliness of patient information by standardizing and automating lab processes,” said Hiroshi Sekiya, Director of Marketing, Olympus America Diagnostic Systems Group. “Through the agreement with Data Innovations, our customers benefit from middleware solutions that are developed by a leading provider with 20 years of knowledge focused on the clinical laboratory.”
“Olympus recognizes that labs are using various approaches such as Lean and Six Sigma to improve processes. We are proud that they chose Data Innovations’ products and services to augment the Olympus automation and instrumentation offerings that support those efforts,” stated Lisa Bromley, Director of Operations, Data Innovations North America.
For more information about Olympus middleware solutions, contact Susan Watanabe, Ph.D., Senior Product Manager, Olympus Diagnostic Systems, at 1-484-896-5686; or visit www.olympusamerica.com.
About Olympus Diagnostic Systems
Olympus Diagnostic Systems provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, maximize productivity, and deliver fast, reliable results.
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
- Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
- Advanced clinical and research microscopes;
- Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;
- Digital cameras and voice recorders.
About Data Innovations:
Data Innovations (DI) is the world’s largest, most successful clinical laboratory middleware company. With offices in the United States, Belgium, Brazil, China, France and the United Kingdom, over 80 employees and US$20+ million in annual sales, DI is the only middleware company with a true global scope and sole focus on laboratory data management. Directly and through our business partnerships, we have installed over 6,500 middleware systems in over 50 countries. Instrument Manager (IM) and Laboratory Production Manager (LPM) represent the most complete offerings in the market for pre-analytical, analytical, and post-analytical sample processing and non clinical tasks such as equipment maintenance. IM and LPM are available independent of instrument, device, or LISvendor, laboratory department, and clinical discipline. Nearly1,000 different instruments, automations systems, and information systems are supported. Equally important to our products are our services which include comprehensive support, on-site consulting and a variety of training options. The American Society of Clinical Laboratory Science (ASCLS) has approved Data Innovations’ Rules training course (Authoring Decision Support Algorithms) for 20 continuing education contact hour credits under their P.A.C.E.® program. The FDA has granted IM 510(k) clearance demonstrating both product excellence and comprehensive development and support systems. For more information about Data Innovations and its products, contact Jennifer Wheeler, Sales & Marketing, at (802) 264-3470, or visit our website at www.datainnovations.com.